Skip to main content

Table 2 Characteristics of participants for the experiments designed to assess the effect of LPS, PMA-ionomycin, Nanoparticles, Micelles, or Cyclic Dinucleotide on cytokine and chemokine response

From: Novel nanoadjuvants balance immune activation with modest inflammation: implications for older adult vaccines

Demographic information- cytokine and chemokine

Young

(mean ± s.e.m.)

Aged

(mean ± s.e.m.)

 

Age (years)

24.6 ± 1.7

78.5 ± 2.3*

*p < 0.001

Body weight

169 ± 17.0

163.7 ± 20.0

p = 0.821

Serum IL-6

12.9 ± 4.9

20.1 ± 2.3

p = 0.325

Female

n = 3

n = 1

 

Male

n = 3

n = 3

Â